BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funnell, C L
Right arrow Articles by Anand, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funnell, C L
Right arrow Articles by Anand, N
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2005;89:694-698
© 2005 BMJ Publishing Group Ltd


EXTENDED REPORT

Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy

C L Funnell1, M Clowes2, N Anand2

1 West Yorkshire Rotation, Clarendon Wing, Leeds General Infirmary, Leeds, UK
2 Department of Ophthalmology, Calderdale and Huddersfield NHS Trust, Huddersfield Royal Infirmary, Huddersfield HD3 3EA, UK

Correspondence to:
Correspondence to:
Mr Nitin Anand
Department of Ophthalmology, Huddersfield Royal Infirmary, Lindley, Huddersfield HD3 3EA, UK; nitin.anand{at}lycos.co.uk

Aims: To compare outcomes of phacoemulsification combined with trabeculectomy (PT) or deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) application.

Methods: Non-randomised, consecutive, retrospective comparative study. 97 eyes of 97 patients (59 PDS, 38 PT) undergoing combined surgery with intraoperative MMC (0.1–0.4 mg/ml for 1–3 minutes) were identified for inclusion in the study.

Results: The probability of maintaining intraocular pressure (IOP) below 19 mm Hg and 15 mm Hg, with a 30% drop from preoperative IOP and without additional medication, 1 year after surgery were 77.6% (95% CI: 67 to 90) and 71.5% (60 to 85) for the PDS group and 89.5% (80 to 99) and 89.5 (80 to 99) for the PT group, respectively, and these differences were not statistically significant (p>0.05, log rank test). After excluding ocular co-morbidity no differences were observed in the improvement of visual acuity between the two groups. There were no major differences in the complication rates except that delayed bleb leaks were seen in seven eyes (18.4%) of the PT group (p = 0.004).

Conclusion: In this study, no statistically significant difference was found in the IOP and visual outcomes between PDS and PT. A significantly higher frequency of late bleb leaks after PT was observed.


Abbreviations: 5-FU, 5-fluorouracil; IOP, intraocular pressure; MMC, mitomycin C; NPGS, non-penetrating glaucoma surgery; PT, phacoemulsification combined with trabeculectomy; PDS, phacoemulsification combined with deep sclerectomy; PVCT, phacoemulsification combined with viscocanalostomy; TDM, trabeculo-Descemet’s membrane

Keywords: cataract surgery; glaucoma surgery; mitomycin C; phacoemulsification; trabeculectomy; deep sclerectomy


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2005 89: 647. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
N Anand, S Arora, and M Clowes
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks
Br. J. Ophthalmol., February 1, 2006; 90(2): 175 - 180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.